Here are three things to know about the transaction.
1. Once the agreement is completed, Providence will retain a 40 percent equity interest in Matrix and have representatives on Matrix’s board. Frazier will own a 60 percent equity interest in Matrix.
2. The transaction values Matrix, which was acquired by Providence in October 2014 for approximately $393 million, at $537.5 million.
3. Providence will receive gross cash proceeds of approximately $418 million before transaction costs, taxes and customary post-closing adjustments, according to both parties.
More articles on transactions and valuations:
SSM Health to take over 26 St. Louis Walgreens in-store clinics
UMass Memorial Health System considers merging Leominster and Clinton campuses
AU Health, Philips roll out advanced life support monitors
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
